BWS Financial Raises Price Target on Barracuda Networks (CUDA) to $30

Rosenblatt Reiterates Buy on Barracuda Networks (CUDA) Following 2Q Report

Rosenblatt reiterated a Buy rating and $30.00 price target on Barracuda Networks (NYSE: CUDA) following the company's 2Q earnings report. EPS came in at $0.21, a penny better than the street while both billings of $100.3 million and revenue of $87.9 million were ahead of guidance and... More

Pre-Open Stock Movers 10/12: (IPCI) (VOXX) (CUDA) Higher; (ERIC) (FTNT) (FEYE) Lower (more...)

Today's Pre-Open Stock Movers:

Intellipharmaceutics International Inc. (Nasdaq: IPCI) 17.7% HIGHER; announced that it has entered into a license and commercial supply agreement with Mallinckrodt LLC (NYSE: MNK), by which the Company has granted Mallinckrodt an exclusive license to market, sell and distribute in the United States the following extended release drug product candidates (the "licensed products") for which Intellipharmaceutics has abbreviated new drug applications ("ANDAs") filed with the U.S. Food and Drug Administration... More

BTIG Lifts PT on Barracuda Networks (CUDA) to $28; Still Sees Plenty of Near-Term Drivers

BTIG lifts its price target on Buy-rated Barracuda Networks (NYSE: CUDA) from $26 to $28 following Q2 results issued Tuesday night.

Analyst Joel Fishbein commented: Billings and revenue beat slightly, suggesting improving momentum in the core business, while the EPS beat (partially aided by... More

Piper Jaffray Upgrades Barracuda Networks (CUDA) to Overweight

Piper Jaffray upgraded Barracuda Networks (NYSE: CUDA) from Neutral to Overweight with a price target of $32.00 (from $18.00).

For an analyst ratings summary and ratings history on Barracuda Networks click here. For more ratings news on Barracuda Networks click here.

Shares of Barracuda Networks closed at $23.33 yesterday.

After-Hours Stock Movers 10/11: (HTGM) (IPCI) (VOXX) Higher; (FTNT) (PFPT) (PANW) Lower (more...)

Today's After-Hours Movers:

HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) 25.3% HIGHER; The company and Merck KGaA, Darmstadt, Germany, have entered a broad companion diagnostics master agreement. The initial development program agreement utilizes the HTG EdgeSeq DLBCL Cell of Origin Assay in the Merck KGaA, Darmstadt, Germany, M7583, selective and irreversible inhibitor of Burton’s Tyrosine Kinase (BTK), program.

Intellipharmaceutics International Inc. (Nasdaq: IPCI)... More

Barracuda Networks (CUDA) Tops Q2 EPS by 8c

Barracuda Networks (NYSE: CUDA) reported Q2 EPS of $0.21, $0.08 better than the analyst estimate of $0.13. Revenue for the quarter came in at $87.9 million versus the consensus estimate of $85.27 million.

"In the second quarter, we are pleased with our financial results, and continue to... More

Wall St. set to open lower ahead of Fed minutes

By Yashaswini Swamynathan

(Reuters) - Wall Street looked set to open lower on Wednesday as investors eyed the finer details of the Federal Reserve's September policy meeting.

While the Fed stood pat on interest rates during the meeting, three members voted for a hike. The minutes will reveal policymakers' views on the progress of the U.S. economy and its ability to absorb an increase this year.

Traders have currently set a 70 percent chance of a rate hike in December, the CME Group's FedWatch tool showed.

"We are going to have to... More

Trading Radar for 10/11: Alcoa (AA), Fastenal (FAST), Barracuda Networks (CUDA) Report

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Earnings:

Alcoa (NYSE: AA) - consensus EPS $0.12
Bank of the Ozarks (Nasdaq: OZRK) - consensus EPS $0.06... More